INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 416m ago
House PTR16m ago
SEC 13F15m ago
Robinhood Chain15m ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,372 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$82K
2,239 sh
Jan 24, 2026
Page 1448 of 1835
← PrevNext →
Jan 26, 2026
traded Jan 24, 2026
+2d
SEC Form 4

Evidence

12
YJ
Yeh Shu-Hua (Joshua)*** See Remarks
AAOIAPPLIED OPTOELECTRONICS, INC.
Tax withholding
F$73K
1,899 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

12
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$788K
5,744 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

12
YJ
Yeh Shu-Hua (Joshua)*** See Remarks
AAOIAPPLIED OPTOELECTRONICS, INC.
Tax withholding
F$98K
2,553 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

12
BK
Bitting KurtDirector, See Remarks
ECVTEcovyst Inc.
Tax withholding
F$174K
16.1K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

12
LT
Lin Chih-Hsiang (Thompson)Director, President and CEO
AAOIAPPLIED OPTOELECTRONICS, INC.
Tax withholding
F$239K
6,230 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

12
CF
Chang Hung-Lun (Fred)*** See Remarks
AAOIAPPLIED OPTOELECTRONICS, INC.
Tax withholding
F$72K
1,874 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
HW
Hicks Bradley W.President of DCS
JBHTHUNT J B TRANSPORT SERVICES INC
Grant or award
A—
7,444 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
FP
Field Darren P.EVP and President Intermodal
JBHTHUNT J B TRANSPORT SERVICES INC
Grant or award
A—
8,393 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
NM
Nora Johnson Suzanne MDirector
INTUINTUIT INC.
Option exercise
M—
586 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
JD
Jedrzejek DavidSVP and General Counsel
LEVILEVI STRAUSS & CO
Grant or award
A—
12.2K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,662 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC Form 4

Evidence

9
CD
Crane Benton DelossDirector
ANGXAngel Studios, Inc.
Option exercise
M—
2,648 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
MT
Mawakana TekedraDirector
INTUINTUIT INC.
Grant or award
A$25K
45 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$42K
1,153 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC Form 4

Evidence

9
HF
Heilbronn FrancoisDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
AP
Ahlstrom PaulDirector
ANGXAngel Studios, Inc.
Option exercise
M—
2,648 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
42.6K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
42.6K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
CN
Cox Erin NealyDirector
SBHSally Beauty Holdings, Inc.
Grant or award
A—
9,975 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
12.2K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
NM
Nora Johnson Suzanne MDirector
INTUINTUIT INC.
Option exercise
M—
694 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
RR
Roslansky RyanDirector
INTUINTUIT INC.
Option exercise
M—
418 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
NM
Nora Johnson Suzanne MDirector
INTUINTUIT INC.
Option exercise
M—
880 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
RR
Rangel Max R.Director
SBHSally Beauty Holdings, Inc.
Grant or award
A—
9,975 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
SJ
Szkutak Thomas JDirector
INTUINTUIT INC.
Option exercise
M$25K
67 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
SJ
Szkutak Thomas JDirector
INTUINTUIT INC.
Option exercise
M$25K
67 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
JJ
Jarrett JenniferChief Operating Officer
RCUSArcus Biosciences, Inc.
Grant or award
A—
126.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
TC
Tang Carolyn C.General Counsel
RCUSArcus Biosciences, Inc.
Grant or award
A—
24.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
NE
Norrod Forrest EugeneDirector
INTUINTUIT INC.
Grant or award
A—
497 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
GC
Goeltz II Robert C.Chief Financial Officer
RCUSArcus Biosciences, Inc.
Grant or award
A—
96.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
DL
Dalzell Richard LDirector
INTUINTUIT INC.
Option exercise
M$31K
82 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
BJ
Boattini JenniferSR VP Legal/General Counsel
JBHTHUNT J B TRANSPORT SERVICES INC
Grant or award
A—
1,708 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
DL
Dalzell Richard LDirector
INTUINTUIT INC.
Grant or award
A$32K
57 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
YJ
Yeh Shu-Hua (Joshua)*** See Remarks
AAOIAPPLIED OPTOELECTRONICS, INC.
Tax withholding
F$23K
609 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
SJ
Szkutak Thomas JDirector
INTUINTUIT INC.
Grant or award
A—
497 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
MT
Mawakana TekedraDirector
INTUINTUIT INC.
Option exercise
M—
694 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
JN
Jain NikunjPrincipal Accounting Officer
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$3,077
7,721 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
NS
Nixon J ScottDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,058 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$376K
2,862 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence